{
    "Trade/Device Name(s)": [
        "Alinity i Total \u03b2-hCG Reagent Kit",
        "Alinity c Glucose Reagent Kit",
        "Alinity c ICT Sample Diluent",
        "Alinity ci-series"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K230790",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170317",
        "K170316",
        "K170320"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA",
        "CFR",
        "JGS",
        "CEM",
        "CGZ",
        "JJE"
    ],
    "Summary Letter Date": "March 21, 2023",
    "Summary Letter Received Date": "March 22, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1155",
        "21 CFR 862.1345",
        "21 CFR 862.1170",
        "21 CFR 862.1600",
        "21 CFR 862.1665",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system",
        "Hexokinase, glucose",
        "Electrode, ion-specific, chloride/potassium/sodium",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Total \u03b2-hCG",
        "Glucose",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Alinity i analyzer",
        "Alinity c analyzer",
        "Alinity ci-series"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)",
        "Spectrophotometry",
        "Potentiometric",
        "Ion-selective electrode"
    ],
    "Methodologies": [
        "Immunoassay",
        "Spectrophotometric measurement",
        "Potentiometric measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent Kit",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for the Abbott Alinity ci-series system and associated reagent kits for quantitative and qualitative measurement of \u03b2-hCG, glucose, sodium, potassium, and chloride in body fluids using automated clinical chemistry and immunoassay technology.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use with automated analysis of \u03b2-hCG (pregnancy), glucose (carbohydrate metabolism disorders), and sodium, potassium, and chloride (electrolyte/metabolic disorders) in serum, plasma, urine, or CSF on the Alinity ci-series system.",
    "fda_folder": "Clinical Chemistry"
}